Cardiac Diagnostics

This channel includes news and new technology innovations for cardiac diagnostic systems or techniques. This includes laboratory testing, blood tests, Tropoin testing, ECG, electrocardiogram systems,  point of care testing systems, genetic testing and studies showing new ways to diagnose heart diseases.

Hormone Therapy Linked to Heart Fat, Hard Arteries

Not all heart fat is equal. Buildup in the pericardium is more strongly associated with heart disease, and seems to increase as estrogen levels drop during menopause. This new study shows that a certain type of hormone replacement therapy could exacerbate the problem, while others may be protective. Image courtesy of Rick Sciullo/UPMC.

News | Womens Cardiovascular Health | August 07, 2019

August 7, 2019 — Hormone replacement therapy is a common treatment for menopause-related symptoms, and new research...

Screen grab of facial scan from the app. Image courtesy of Kang Lee.

Screen grab of facial scan from the app. Image courtesy of Kang Lee.

News | Blood Pressure Monitor | August 06, 2019

August 6, 2019 — Blood...

Artificial Intelligence Improves Heart Attack Risk Assessment
News | CT Angiography (CTA) | August 06, 2019

August 6, 2019 — When used with a common heart scan, machine learning, a type of...

Digital Health Devices Used at Point of Care May Improve Diagnostic Certainty
News | Point of Care Testing | August 05, 2019

August 5, 2019 — A West Virginia-based rural medical outreach event showcased the use of...

In June 2019, Medis received clearance from the U.S. Food and Drug Administration for its QAngio XA 3D technology (QFR). The FFR-angio technology can show the FFR readings in a 3-D image and overlaid on a fluoro image.

In June 2019, Medis received clearance from the U.S. Food and Drug Administration for its QAngio XA 3D technology (QFR). The FFR-angio technology can show the FFR readings in a 3-D image and overlaid on a fluoro image. 

Feature | FFR Technologies | August 05, 2019 | Dave Fornell and Greg Freiherr

New technologies have been developed that may replace the traditional pressure wires and adenosine to assess the...

Coronary CT angiography images of a coronary artery depicting the perivascular fat attenuation index (FAI) before and after biologic therapy at one-year follow-up. Patients had excellent response to biologic therapy, showing clear reductions in the inflammation in plaques that cause heart attacks and stokes. Image from the Oxford Academic Cardiovascular CT Core Lab and Lab of Inflammation and Cardiometabolic Diseases at NHLBI.

Coronary CT angiography images of a coronary artery depicting the perivascular fat attenuation index (FAI) before and after psoriasis biologic drug therapy at one-year follow-up. Patients had excellent response to biologic therapy, showing clear reductions in the inflammation in plaques that cause heart attacks and stokes. Image from the Oxford Academic Cardiovascular CT Core Lab and Lab of Inflammation and Cardiometabolic Diseases at NHLBI.

 

Feature | Pharmaceuticals | July 31, 2019

July 31, 2019 — Researchers found anti-inflammatory drug therapies used to treat moderate to severe psoriasis can...

Eko Launches Eko Home Cardiac Remote Monitoring Application
News | Remote Monitoring | July 31, 2019

July 31, 2019 — Silicon Valley-based digital health company Eko announced Eko Home, a new service that enables...

Evolutionary Gene Loss May Help Explain Human Predisposition to Heart Attacks
News | Cardiac Diagnostics | July 29, 2019

July 29, 2019 — The loss of a single gene two to three million years ago in our ancestors may have resulted in a...

Dr. Markus Krane, deputy director of the Cardiac and Vascular Surgery Unit at the DHM helped compile an atlas of the heart and discovered myosin binding protein H-like (MYBPHL) occurs only in the atria of the heart. Researchers began using it as a blood test biomarker to assess the success of atrial fibrillation ablation procedures.

Dr. Markus Krane, deputy director of the Cardiac and Vascular Surgery Unit at the DHM helped compile an atlas of the heart and discovered myosin binding protein H-like (MYBPHL) occurs only in the atria of the heart. Researchers began using it as a blood test biomarker to assess the success of atrial fibrillation ablation procedures.

Feature | Atrial Fibrillation | July 24, 2019

July 24, 2019 — Atrial fibrillation (AFib) is a common abnormal heart rhythm. It is treated either with medications...

With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a costly tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. The image shows how SPECT allows the reader to distinguish between blood pool activity and radiotracer uptake.

With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a costly tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. This is Figure 2, showing how SPECT imaging allows the reader to distinguish between blood pool activity (ventricular cavity, etc) and myocardial activity and identify regional myocardial differences in radiotracer uptake.

Feature | Nuclear Imaging | July 22, 2019 | Christopher A. Hanson M.D., and Jamieson M. Bourque M.D., MHS

Cardiac amyloidosis is a highly morbid and underdiagnosed infiltrative cardiomyopathy that is characterized by the...

New Technology Improves Atrial Fibrillation Detection After Stroke
News | Atrial Fibrillation | July 19, 2019

July 19, 2019 — A new method of evaluating irregular heartbeats outperformed the approach that’s currently used...

FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019

July 15, 2019 — The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac...

Overlay Init